On Friday, a special FDA committee will review the Johnson & Johnson Covid-19 vaccine and decide whether to recommend it for Emergency Use Authorization. The committee members include academics, physicians, and government employees who are experts in the field of infectious diseases and vaccines. In an eight-hour meeting on February 26th, the committee members will discuss issues like how effective the vaccine is and if there are any side effects. At the end of the meeting, the committee will vote to decide if the vaccine should be recommended to the FDA for Emergency Use Authorization.If they vote yes, the FDA...